Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDENTIFY: IL-6 Guided Treatment in AHRF
NCT07334379Phase 2Recruiting
- Start
- Oct 2025
- Primary completion
- Feb 2027
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab, dexamethasone in acute hypoxemic respiratory failure (AHRF). Started Oct 2025; status: recruiting.
02
Drugs
tocilizumabdexamethasone
03
Conditions
acute hypoxemic respiratory failure (AHRF)
Beyond the preview
Go deeper on NCT07334379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07334379.